Phase II results with recombinant interferons: renal cell carcinoma and malignant melanoma.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/91FD111B.svg?ark=w1%2F20260515%2F91FD111B)](https://nobleid.org/work/w1/20260515/91FD111B)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors